BeOne Medicines Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BeOne Medicines Ltd - ADR
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne’s revenue.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy BeOne Medicines Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BeOne Medicines Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BeOne Medicines Ltd - ADR is ONC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BeOne Medicines Ltd - ADR has its primary listing on NASDAQ. You can trade BeOne Medicines Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BeOne Medicines Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BeOne Medicines Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BeOne Medicines Ltd - ADR.